Arrivent Biopharma, Inc. (AVBP) Live Share Price, Invest From India

Arrivent Biopharma, Inc. Stock Performance

as on March 21, 2026 at 6:59 am IST

Day's Low
Day's High
$21.94
Day's Price Range
$23.10
$22.06
0.54%
Downside
4.71%
Upside
52 Week's Low
52 Week's High
$15.47
52-Week Price Range
$27.22
$22.06
29.87%
Downside
23.39%
Upside

Arrivent Biopharma, Inc. share price movements today

Previous Close: $22.86
Open: $23.04
Volume: 257.6K
Day's Low - High: $21.94 - $23.10
52 Week Low - High: $15.47 - $27.22

Arrivent Biopharma, Inc. Historical Returns

1 Month Return: -4.22 %
3 Month Return: + 0.05 %
1 Year Return: + 12.81 %
3 Year Return: 0 %
5 Year Return: 0 %

Arrivent Biopharma, Inc. Stock Fundamentals & Key Indicators

Check Arrivent Biopharma, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-4.2838

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-58.88%

Arrivent Biopharma, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arrivent Biopharma, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Arrivent Biopharma, Inc.	BUY	$1.0B	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.3B	116.54%	133.52	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$116.3B	110.08%	29.94	32.94%
Beone Medicines Ltd	NA	$32.5B	NA	114.93	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.0B	54.71%	17.8	31.41%

Stock Returns calculator for Arrivent Biopharma, Inc. Stock including INR - Dollar returns

The Arrivent Biopharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Arrivent Biopharma, Inc. investment value today

Current value as on today

₹1,22,457

Returns

₹22,457

(+22.46%)

Returns from Arrivent Biopharma, Inc. Stock

₹13,012 (+13.01%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Arrivent Biopharma, Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Arrivent Biopharma, Inc.. Average target price of $40.44

Arrivent Biopharma, Inc. Share Price Target

Get share price movements and forecasts by analysts on Arrivent Biopharma, Inc..

What analysts predicted

45.45%UPSIDE

Target Price

$40.44

Current Price

$22.06

Analyzed by

11 Analysts

Target

$40.44

Arrivent Biopharma, Inc. target price $40.44, a slight upside of 45.45% compared to current price of $22.06. According to 11 analysts rating.

Arrivent Biopharma, Inc. Stock’s Investor Sentiment and Interest

Search interest for Arrivent Biopharma, Inc. Stock has decreased by -77% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 20, 2026 to March 22, 2026

Change:-77% versus previous 30 day period

Arrivent Biopharma, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-16	-23	-20	-25	-24	-23	-66	-33	-38	-38
EBITDA	-16	-23	-20	-25	-24	-23	-66	-31	-34	-38
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-14	-21	-17	-21	-20	-20	-64	-31	-34	-35
Income Tax Expense	-16	-23	-	-	-	-	-	-	-	-
Net Income	-14	-21	-17	-21	-20	-20	-64	-31	-34	-35
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Arrivent Biopharma, Inc. Annual Profit & Loss

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-36	-74	-94	-177
EBITDA	-36	-74	-80	-177
Interest Expense	-	-	-	-
Depreciation	-	-	-	-
Income Before Tax	-36	-69	-80	-166
Income Tax Expense	-36	-	-80	-
Net Income	-36	-69	-80	-166
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Arrivent Biopharma, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-21	-17	-21	-20	-20	-64	-31	-34	-35
Operating Cash Flow	-14	-18	-19	-16	-16	-68	-26	-35	-30
Investing Cash Flow	25	-	-	-	-192	36	13	-50	-71
Financing Cash Flow	-1	185	0	0	0	6	75	86	34
Change in Cash	9	167	-18	-15	-208	-24	62	0	-67

Arrivent Biopharma, Inc. Annual Cash Flow

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	-36	-69	-80	-166
Operating Cash Flow	-43	-55	-70	-160
Investing Cash Flow	-	-	-192	-71
Financing Cash Flow	169	42	186	203
Change in Cash	126	-12	-76	-28

Insights on Arrivent Biopharma, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, AVBP has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Price Dip
In the last 7 days, AVBP stock has moved down by -7.9%

About Arrivent Biopharma, Inc.

ArriVent BioPharma, Inc. is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The Company is focused on maximizing the potential of its lead development candidate, firmonertinib, and advancing a pipeline of novel therapeutics, such as antibody drug conjugates (ADCs), through approval and commercialization. Firmonertinib is an oral, highly brain-penetrant, and broadly active mutation-selective epidermal growth factor receptor (EGFR) inhibitor active against both classical and uncommon EGFR mutations, including PACC and exon 20 insertion mutations. Firmonertinib is also being studied in a clinical combination study targeting advanced or metastatic NSCLC patients with EGFR classical mutations. It is developing ARR-217, an ADC for the treatment of gastrointestinal cancers. Its ARR-002 candidate is focused on the treatment of solid tumors.

Organisation	Arrivent Biopharma, Inc.
Headquarters	18 Campus Boulevard, Newtown Square, PA, United States, 19073
CEO	Dr. Zhengbin Yao Ph.D.
E-voting on shares	Click here to vote

Key Management of Arrivent Biopharma, Inc.

Name	Title
Mr. Brent S. Rice	Chief Commercial Officer
Dr. Zhengbin Yao Ph.D.	Co-Founder, Chairman, President & CEO
Dr. Stuart Lutzker M.D., Ph.D.	Co-Founder, President of Research & Development and Director
Mr. Winston Kung M.B.A.	CFO & Treasurer
Ms. Robin LaChapelle M.A.	Co-Founder & COO
Ms. Yang Wang Ph.D.	Chief Technology Officer
Dr. James Paul Kastenmayer J.D., Ph.D.	General Counsel & Secretary

FAQs

What is Arrivent Biopharma, Inc. share price today?

Arrivent Biopharma, Inc. share price today is $22.06 as on March 21, 2026 at 1:29 am IST at the close of the market. Arrivent Biopharma, Inc. share today touched a day high of $23.1 and a low of $21.94.

What is the 52 week high and 52 week low for Arrivent Biopharma, Inc. share?

Arrivent Biopharma, Inc. share touched a 52 week high of $27.22 on March 4, 2026 and a 52 week low of $15.47 on April 7, 2025. Arrivent Biopharma, Inc. stock price today i.e. March 21, 2026 at 1:29 am IST is closed at $22.06,which is 18.96% down from its 52 week high and 42.60% up from its 52 week low.

What is Arrivent Biopharma, Inc.'s market capitalisation today?

Arrivent Biopharma, Inc. market capitalisation is $0.00T as on March 21, 2026 at 1:29 am IST.

How to invest in Arrivent Biopharma, Inc. Stock (AVBP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Arrivent Biopharma, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arrivent Biopharma, Inc. Shares that will get you 0.0680 shares as per Arrivent Biopharma, Inc. share price of $22.06 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Arrivent Biopharma, Inc. Stock (AVBP) from India?

Indian investors can start investing in Arrivent Biopharma, Inc. (AVBP) shares with as little as ₹93.652 or $1 (as of March 22, 2026 at 11:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Arrivent Biopharma, Inc. stock (as per the Rupee-Dollar exchange rate as on March 22, 2026 at 11:40 pm IST). Based on Arrivent Biopharma, Inc. share’s latest price of $22.06 as on March 21, 2026 at 1:29 am IST, you will get 0.4533 shares of Arrivent Biopharma, Inc.. Learn more about fractional shares .